Lena has over 35 years of experience within the global Medtech & pharma industry, where she has held several commercial positions, including at Sectra/Philips, Aerocrine and Pharmacia. Lately, as the business area manager for digital pathology at ContextVision AB she oversaw the development and CE-marking of INIFY, an AI-based decision support tool for prostate cancer. Now she works as an independent consultant. She is chairman of the board at Neores AB, a member of the board at Zenicor AB and a board observer at Spotlight Pathology.